Contenu

Université de Toulouse Université Toulouse III - Paul Sabatier

Presse Annuaire Recherche avancée
22 juin

Vous êtes ici : Accueil > La recherche

Recherche

Imagerie oncologique : ouvrir la voie à l'oncologie de précision

Colloque/Séminaire/Conférences-Rencontres/Débats

Récipiendaire du titre de Docteur Honoris Causa de l'université Toulouse III - Paul Sabatier cette année, Hedvig HRICAK présentera la veille de la cérémonie une conférence sur l'imagerie oncologique.

Over the last 4 decades, oncologic imaging has evolved at an accelerating pace. Today oncologic imaging is an essential tool for almost all types of cancer and at virtually every step of care, from diagnosis, staging and treatment decision-making to treatment response assessment and the detection of recurrence. However, looking forward, it is apparent that actually, we are only at the beginning of the evolution of the field, harvesting impressive anatomic information and starting to understand molecular and functional potential of imaging. Today, we are at the start of a new era of rapid technological and scientific progress that is affecting nearly every aspect of modern life, and oncologic imaging is no exception. Innovations in imaging technologies, molecular imaging and therapy probe development, and advances in computer science are creating unprecedented opportunities for enhancing the power of diagnostic imaging, radionuclide therapy and interventional radiology. Radiologist and nuclear medicine physicians are in a position to dramatically enhance the array and value of services they offer for the care of patients with cancer, from molecular precision in diagnosis to the development of new theranostics and other therapies. It is imperative that we seize the opportunities in front of us to strengthen and broaden the horizons of oncologic imaging and therapy and, ever more important, improve the lives of patients with cancer.

Hedvig Hricak is Chair, Department of Radiology, Memorial Sloan-Kettering Cancer Center, a member of the Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, and Professor, Gerstner Sloan-Kettering Graduate School of Biomedical Sciences. The hallmark of her research career has been the development, validation and dissemination of new diagnostic imaging techniques, particularly for oncology. Over the years, she has served on the executive boards of numerous national and international societies and, through dedicated mentorship, has shaped the careers of many young radiologists around the world. She is a member of National Academy of Medicine-National Academy of Sciences of the United States.
 

Dates
le 4 juin 2018
à 13h
Lieu(x)
Amphithéâtre de l'IUCT - Oncopole

Date de mise à jour 24 mai 2018


Recherche d'une actualité

Recherche d'une actualité

Université Toulouse III - Paul Sabatier - 118 route de Narbonne 31062 TOULOUSE CEDEX 9 téléphone +33 (0)5 61 55 66 11